keyword
https://read.qxmd.com/read/38694088/amino-acid-hplc-fld-analysis-of-spirulina-and-its-protective-mechanism-against-the-combination-of-obesity-and-colitis-in-wistar-rats
#21
JOURNAL ARTICLE
Fatma Arrari, Mohamed-Amine Jabri, Ala Ayari, Nouha Dakhli, Chayma Ben Fayala, Samir Boubaker, Hichem Sebai
OBJECTIVE: The cafeteria diet (CD), designed as an experimental diet mimicking the obesogenic diet, may contribute to the pathogenesis of inflammatory bowel diseases (IBD). This study delves into the influence of spirulina (SP) on obesity associated with colitis in Wistar rats. METHODS: The amino acids composition of SP was analyzed using HPLC-FLD. Animals were equally separated into eight groups, each containing seven animals and treated daily for eight weeks as follows: Control diet (SD), cafeteria diet (CD) group, CD + SP (500 mg/kg) and SD + SP...
May 15, 2024: Heliyon
https://read.qxmd.com/read/38692877/-a-new-treatment-option-for-complex-perianal-fistulas-in-crohn-s-disease-patients-development-of-darvadstrocel-allogeneic-expanded-adipose-derived-mesenchymal-stem-cells-in-japan
#22
JOURNAL ARTICLE
Takayoshi Yamaguchi
Crohn's disease (CD) is a chronic and relapsing inflammatory bowel disease affecting the entire gastrointestinal tract. The prevalence of CD among Japanese people is increasing. One of the most frequent complications of CD is perianal fistulas. People living with CD may experience complex perianal fistulas, which can cause intense pain, bleeding, swelling, infection, and anal discharge. Despite medical and surgical advancements, complex perianal fistulas in CD remain challenging for clinicians to treat. CD patients living with perianal fistulas reported a negative impact on many aspects of their quality of life...
2024: Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
https://read.qxmd.com/read/38692122/acute-presentation-of-cocoon-abdomen-as-intestinal-obstruction-mimicking-with-strangulated-eventration-a-case-report
#23
S Bourabaa, O Bourouail, A Mansouri, M Zhim, E Echarrab, H El Alami
INTRODUCTION: Abdominal cocoon syndrome (ACS), or sclerosing encapsulating peritonitis (SEP) is a rare cause of intestinal obstruction in which the bowel and internal abdominal organs are wrapped with a fibrocollagenous cocoon-like encapsulating membrane. While cocooning of the abdomen primarily manifests in individuals undergoing peritoneal dialysis (PD), it has also been reported to occur spontaneously. Remarkably rare, SEP may present with complete mechanical bowel obstruction in select cases...
April 20, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38691917/anti-inflammatory-and-protective-effects-of-aripiprazole-on-tnbs-induced-colitis-and-associated-depression-in-rats-role-of-kynurenine-pathway
#24
JOURNAL ARTICLE
Afrooz Mohammadgholi-Beiki, Mohammad Sheibani, Majid Jafari-Sabet, Manijeh Motevalian, Parvaneh Rahimi-Moghaddam
BACKGROUND: The prevalence of depression is higher in patients with inflammatory bowel disease (IBD) than in the general population. Inflammatory cytokines and the kynurenine pathway (KP) play important roles in IBD and associated depression. Aripiprazole (ARP), an atypical antipsychotic, shows various anti-inflammatory properties and may be useful in treating major depressive disorder. This study aimed to evaluate the protective effects of ARP on TNBS-induced colitis and subsequent depression in rats, highlighting the role of the KP...
April 29, 2024: International Immunopharmacology
https://read.qxmd.com/read/38690831/fibrostricturing-crohn-s-disease-is-marked-by-an-increase-in-active-eosinophils-in-the-deeper-layers
#25
JOURNAL ARTICLE
Inge Jacobs, Bo-Jun Ke, Matthias Ceulemans, Jonathan Cremer, André D'Hoore, Gabriele Bislenghi, Gianluca Matteoli, Gert De Hertogh, João Sabino, Marc Ferrante, Séverine Vermeire, Christine Breynaert, Tim Vanuytsel, Bram Verstockt
INTRODUCTION: Approximately 50% of Crohn's disease (CD) patients develop intestinal strictures necessitating surgery. The immune cell distribution in these strictures remains uncharacterized. We aimed to identify the immune cells in intestinal strictures of CD patients. METHODS: During ileocolonic resections, transmural sections of terminal ileum were sampled from 25 CD patients and 10 non-inflammatory bowel disease (IBD) controls. Macroscopically, unaffected, fibrostenotic and inflamed ileum was collected and analysed for immune cell distribution (flow cytometry) and protein expression...
May 1, 2024: Clinical and Translational Gastroenterology
https://read.qxmd.com/read/38690795/cytomegalovirus-infection-in-adult-patients-with-inflammatory-bowel-disease-a-literature-review
#26
REVIEW
Zahra Momayaz Sanat, Zeinab Siami, Sudabeh Alatab, Homayoon Vahedi, Zeinab Fanni
Human cytomegalovirus (HCMV) is classified within the Herpesvirales order and is prevalent in 50%‒80% of the general population. Most carriers experience this infection without noticeable clinical symptoms. HCMV causes a lifelong latent infection that can be reactivated due to immune disorders and inflammation. The reactivation of HCMV becomes particularly significant when it coincides with inflammatory bowel disease (IBD). While cytomegalovirus (CMV) colitis in IBD patients was identified years ago, the role of CMV in triggering flare-ups, acute severe colitis, treatment resistance, and other outcomes in IBD patients experiencing CMV reactivation remains a subject of ongoing debate...
May 1, 2024: Archives of Iranian Medicine
https://read.qxmd.com/read/38690290/gastrointestinal-microbiota-directed-nutritional-and-therapeutic-interventions-for-inflammatory-bowel-disease-opportunities-and-challenges
#27
REVIEW
Devendra Paudel, Divek V T Nair, Grace Joseph, Rita Castro, Amit K Tiwari, Vishal Singh
Evidence-based research has confirmed the role of gastrointestinal microbiota in regulating intestinal inflammation. These data have generated interest in developing microbiota-based therapies for the prevention and management of inflammatory bowel disease (IBD). Despite in-depth understanding of the etiology of IBD, it currently lacks a cure and requires ongoing management. Accumulating data suggest that an aberrant gastrointestinal microbiome, often referred to as dysbiosis, is a significant environmental instigator of IBD...
2024: Gastroenterology Report
https://read.qxmd.com/read/38690023/chitin-glucan-improves-important-pathophysiological-features-of-irritable-bowel-syndrome
#28
JOURNAL ARTICLE
Caroline Valibouze, Caroline Dubuquoy, Philippe Chavatte, Michaël Genin, Veronique Maquet, Salvatore Modica, Pierre Desreumaux, Christel Rousseaux
BACKGROUND: Irritable bowel syndrome (IBS) is one of the most frequent and debilitating conditions leading to gastroenterological referrals. However, recommended treatments remain limited, yielding only limited therapeutic gains. Chitin-glucan (CG) is a novel dietary prebiotic classically used in humans at a dosage of 1.5-3.0 g/d and is considered a safe food ingredient by the European Food Safety Authority. To provide an alternative approach to managing patients with IBS, we performed preclinical molecular, cellular, and animal studies to evaluate the role of chitin-glucan in the main pathophysiological mechanisms involved in IBS...
April 28, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38689088/tlr7-dependent-eosinophil-degranulation-links-psoriatic-skin-inflammation-to-small-intestinal-inflammatory-changes-in-mice
#29
JOURNAL ARTICLE
Hee Joo Kim, Jinsun Jang, Kunhee Na, Eun-Hui Lee, Hyeon-Jung Gu, Yoon Hee Lim, Seul-A Joo, Seung Eun Baek, Joo-Young Roh, Han-Joo Maeng, Yun Hak Kim, Young-Jae Lee, Byung-Chul Oh, YunJae Jung
Recent evidence of gut microbiota dysbiosis in the context of psoriasis and the increased cooccurrence of inflammatory bowel disease and psoriasis suggest a close relationship between skin and gut immune responses. Using a mouse model of psoriasis induced by the Toll-like receptor (TLR) 7 ligand imiquimod, we found that psoriatic dermatitis was accompanied by inflammatory changes in the small intestine associated with eosinophil degranulation, which impaired intestinal barrier integrity. Inflammatory responses in the skin and small intestine were increased in mice prone to eosinophil degranulation...
May 1, 2024: Experimental & Molecular Medicine
https://read.qxmd.com/read/38684238/alzheimer-s-disease-related-presenilins-are-key-to-intestinal-epithelial-cell-function-and-gut-immune-homoeostasis
#30
JOURNAL ARTICLE
Lena Erkert, Reyes Gamez-Belmonte, Melanie Kabisch, Lena Schödel, Jay V Patankar, Miguel Gonzalez-Acera, Mousumi Mahapatro, Li-Li Bao, Christina Plattner, Anja A Kühl, Jie Shen, Lutgarde Serneels, Bart De Strooper, Markus F Neurath, Stefan Wirtz, Christoph Becker
OBJECTIVE: Mutations in presenilin genes are the major cause of Alzheimer's disease. However, little is known about their expression and function in the gut. In this study, we identify the presenilins Psen1 and Psen2 as key molecules that maintain intestinal homoeostasis. DESIGN: Human inflammatory bowel disease (IBD) and control samples were analysed for Psen1 expression. Newly generated intestinal epithelium-specific Psen1-deficient, Psen2-deficient and inducible Psen1/Psen2 double-deficient mice were used to dissect the functional role of presenilins in intestinal homoeostasis...
April 29, 2024: Gut
https://read.qxmd.com/read/38682122/cardiovascular-comorbidities-and-inflammatory-bowel-disease-causes-and-consequences
#31
JOURNAL ARTICLE
Preetika Sinh, Raymond K Cross
Patients with inflammatory bowel disease (IBD) have an increased risk of cardiovascular disease (CVD) such as myocardial infarction and stroke. CVD in patients with IBD might occur in those with younger age and active disease, which are not traditional risk factors of CVD. Atherosclerotic CVD (ASCVD) and IBD are both proinflammatory conditions, and the underlying chronic inflammation might drive ASCVD risk. Decreasing inflammation might reduce this risk; however, data are limited. IBD medications can increase or decrease ASCVD risk...
April 2024: Gastroenterology & Hepatology
https://read.qxmd.com/read/38681982/probiotics-shaping-the-gut-immunological-responses
#32
REVIEW
Eirini Filidou, Leonidas Kandilogiannakis, Anne Shrewsbury, George Kolios, Katerina Kotzampassi
Probiotics are live microorganisms exerting beneficial effects on the host's health when administered in adequate amounts. Among the most popular and adequately studied probiotics are bacteria from the families Lactobacillaceae , Bifidobacteriaceae and yeasts. Most of them have been shown, both in vitro and in vivo studies of intestinal inflammation models, to provide favorable results by means of improving the gut microbiota composition, promoting the wound healing process and shaping the immunological responses...
April 21, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38681263/a-mini-literature-review-of-probiotics-transforming-gastrointestinal-health-through-evidence-based-insights
#33
REVIEW
Cara Mohammed, Jhon P Fuego, Karina V Garcia, Hira Jamil, Rahul Y Rajesh, Andres S Escobar, Muhammad J Hassan, Manju Rai
As our understanding of the intricate interaction between gut bacteria and human health continues to expand, so too has interest in the ability of probiotics to manage gut microbiota and confer multiple health benefits to the host. The mini literature review focuses on the expanding potential of the use of probiotics in GI health, with a focus on probiotics' potential therapeutic advantages in a variety of gastrointestinal (GI) illnesses. Probiotics play a significant role in managing diarrhea and symptoms of irritable bowel syndrome with diarrhea (IBS-D) by modulating gut microbial communities...
March 2024: Curēus
https://read.qxmd.com/read/38681124/bowel-function-and-inflammation-is-motility-the-other-side-of-the-coin
#34
EDITORIAL
Alba Panarese
Digestion and intestinal absorption allow the body to sustain itself and are the emblematic functions of the bowel. On the flip side, functions also arise from its role as an interface with the environment. Indeed, the gut houses microorganisms, collectively known as the gut microbiota, which interact with the host, and is the site of complex immune activities. Its role in human pathology is complex and scientific evidence is progressively elucidating the functions of the gut, especially regarding the pathogenesis of chronic intestinal diseases and inflammatory conditions affecting various organs and systems...
April 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38680913/recombinant-probiotic-lactococcus-lactis-delivering-p62-mitigates-moderate-colitis-in-mice
#35
JOURNAL ARTICLE
Juliana Guimarães Laguna, Andria Dos Santos Freitas, Fernanda Alvarenga Lima Barroso, Luís Cláudio Lima De Jesus, Octávio Augusto Greco Gomes De Vasconcelos, Ludmila Silva Quaresma, Monique Ferrary Américo, Gabriela Munis Campos, Rafael de Assis Glória, Joyce da Cruz Ferraz Dutra, Tales Fernando Da Silva, Kátia Duarte Vital, Simone O Fernandes, Ramon O Souza, Flaviano Dos Santos Martins, Enio Ferreira, Túlio Marcos Santos, Alexander Birbrair, Marcos Felipe Andrade De Oliveira, Ana Maria Caetano Faria, Rodrigo Dias de Oliveira Carvalho, Franco Maria Venanzi, Yves Le Loir, Gwénaël Jan, Éric Guédon, Vasco Ariston de Carvalho Azevedo
INTRODUCTION AND OBJECTIVE: p62 is a human multifunctional adaptor protein involved in key cellular processes such as tissue homeostasis, inflammation, and cancer. It acts as a negative regulator of inflammasome complexes. It may thus be considered a good candidate for therapeutic use in inflammatory bowel diseases (IBD), such as colitis. Probiotics, including recombinant probiotic strains producing or delivering therapeutic biomolecules to the host mucosal surfaces, could help prevent and mitigate chronic intestinal inflammation...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38680110/epidemiology-of-disorders-of-the-gut-brain-interaction-an-appraisal-of-the-rome-iv-criteria-and-beyond
#36
REVIEW
Gautam Ray, Uday Chand Ghoshal
Disorders of the gut-brain interaction (DGBIs) are presently classified into mutually exclusive anatomical area-related symptom-based categories according to the Rome IV criteria. The pathophysiology of visceral nociception, which contributes to the wide range of symptoms of DGBIs, involves complex psychobiological processes arising from the bidirectional interactions of multiple systems at the gut and brain levels, which affect symptom expression and illness behaviors. The attitude toward an illness and expression of pain and bowel habit vary across cultures with variable interpretation based on sociocultural beliefs, which may not tally with the medical definitions...
April 29, 2024: Gut and Liver
https://read.qxmd.com/read/38679799/fat-and-proteolysis-due-to-methionine-tryptophan-and-niacin-deficiency-leads-to-alterations-in-gut-microbiota-and-immune-modulation-in-inflammatory-bowel-disease
#37
JOURNAL ARTICLE
Tomoaki Hara, Sikun Meng, Daisuke Motooka, Hiromichi Sato, Yasuko Arao, Yoshiko Tsuji, Takeshi Yabumoto, Yuichiro Doki, Hidetoshi Eguchi, Shizuka Uchida, Hideshi Ishii
Inflammatory bowel disease (IBD) is one of the intractable diseases. Nutritional components associated with IBD have been identified, and it is known that excessive methionine intake exacerbates inflammation, and that tryptophan metabolism is involved in inflammation. Analysis of the gut microbiota has also progressed, where Lactobacillus regulate immune cells in the intestine and suppress inflammation. However, whether the methionine and tryptophan metabolic pathways affect the growth of intestinal Lactobacillus is unknown...
April 28, 2024: Cancer Science
https://read.qxmd.com/read/38678319/modification-of-experimental-model-of-necrotizing-enterocolitis-nec-in-rat-pups-by-single-exposure-to-hypothermia-and-hypoxia-and-impact-of-mother-s-milk-on-incidence-of-disease
#38
JOURNAL ARTICLE
Marek Wolski
BACKGROUND Necrotizing enterocolitis (NEC) is a potentially life-threatening disease that affects the intestine of the neonate, causing necrosis and general inflammation. Treatment consists of feeding cessation and antibiotic therapy. In more severe cases, surgical intervention is necessary. Recently, different NEC models have been used to study the development of novel diagnostic and therapeutic methods. This work modified an experimental NEC model in rat pups by a single exposure of animals to NEC-causing factors and testing the impact of mother's milk on prevalence of the disease...
April 28, 2024: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://read.qxmd.com/read/38677716/screening-of-probiotic-strains-to-improve-visceral-hypersensitivity-in-irritable-bowel-syndrome-by-using-in-vitro-and-in-vivo-approaches
#39
JOURNAL ARTICLE
E Torres-Maravilla, F A Carvalho, S Holowacz, J Delannoy, L Lenoir, E Jacouton, F Barbut, P Langella, L G Bermúdez-Humarán, A-J Waligora-Dupriet
Oral administration of probiotics has been proposed as a promising biotherapy to prevent and treat different diseases related to gastrointestinal disorders, such as irritable bowel syndrome (IBS). Due to the increasing research area on the characterisation of new probiotic bacterial strains, it is necessary to perform suitable in vitro experiments, using pertinent cellular models, in order to establish appropriate readout profiles based on IBS symptoms and subtypes. In this work, a collection of 30 candidate strains, belonging mainly to the Lactobacillus and Bifidobacterium genera, were screened using three different sets of in vitro experiments with different readouts to identify promising probiotic strains with: (1) the ability to inhibit the synthesis of IL-8 production by TNF-α stimulated HT-29 cells, (2) immunomodulatory properties quantified as increased IL-10 levels in peripheral blood mononuclear cell (PBMCs), and (3) the ability to maintain epithelial barrier integrity by increasing the trans-epithelial/endothelial electrical resistance (TEER) values in Caco-2 cells...
April 30, 2024: Beneficial Microbes
https://read.qxmd.com/read/38676845/very-early-onset-inflammatory-bowel-disease-in-an-infant-with-a-partial-ripk1-deletion
#40
JOURNAL ARTICLE
Ceyda Tuna Kırsaçlıoğlu, Alexandra Frohne, Zarife Kuloğlu, Isidora Kristofersdottir, Engin Demir, Cansu Altuntaş, Zehra Şule Haskoloğlu, Fatma Nazan Çobanoğlu, Tanıl Kendirli, Halil Özdemir, Zeynep Birsin Özçakar, Berna Savaş, Figen Doğu, Aydan İkincioğulları, Kaan Boztug, Aydan Kansu
The monogenic causes of very-early-onset inflammatory bowel disease (VEO-IBD) have been defined by genetic studies, which were usually related to primary immunodeficiencies. Receptor-interacting serine/threonine-protein kinase-1 (RIPK1) protein is an important signalling molecule in inflammation and cell death pathways. Its deficiency may lead to various clinical features linked to immunodeficiency and/or inflammation, including IBD. Here, we discuss an infant with malnutrition, VEO-IBD, recurrent infections and polyathritis who has a homozygous partial deletion in RIPK1 gene...
April 27, 2024: Journal of Clinical Immunology
keyword
keyword
58036
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.